The local treatment modalities in FIGO stage I‐II small‐cell carcinoma of the cervix are determined by disease stage and lymph node status
Authors:
Open Access
- 14 March 2016
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 5 (6) , 1108-1115
Abstract
The purpose of this study was to identify the optimal local treatment modalities for International Federation of Gynecology and Obstetrics (FIGO) stage I‐II small‐cell carcinoma of the cervix (SCCC), including cancer‐directed surgery (CDS) and/or radiotherapy (RT). The Surveillance Epidemiology and End Results (SEER) database was used to identify SCCC patients from 1988 to 2012, and analyzed using Kaplan–Meier survival and Cox regression proportional hazard methods to determine factors significant for cause‐specific survival (CSS) and overall (OS). A total of 208 patients of SCCC were enrolled. The median follow‐up time was 31 months. Fifty‐eight (27.9%) patients were treated with primary CDS, 88 (42.3%) patients underwent CDS combined with RT, and 62 (29.8%) patients were treated with primary RT. Univariate and multivariate analyses showed that local treatment modalities were independent prognostic factors for CSS and OS. Patients who had undergone CDS had better CSS and OS, compared with patients who had been treated with combined CDS and RT or RT alone. The 5‐year CSS and OS of entire group was 49.8% and 46.4%, respectively. The 5‐year CSS in the groups of patients receiving CDS, CDS combined with RT, and RT alone were 67.9%, 49.7%, and 32.6%, respectively (P < 0.001). The 5‐year OS in patients treated with CDS, CDS combined with RT, and RT alone were 64.9%, 46.2%, and 28.8% (P < 0.001). Primary surgery was associated with improved CSS and OS for FIGO stage I and lymph node negative disease. Primary surgery is the most effective local treatment for FIGO stage I‐II SCCC, as adjuvant RT or radical RT does not improve survival compared to radical surgery, especially in patients with FIGO stage I and lymph node negative disease.Keywords
Funding Information
- National Natural Science Foundation of China (81402527)
This publication has 18 references indexed in Scilit:
- Primary surgery versus primary radiation therapy for FIGO stages I–II small cell carcinoma of the uterine cervix: A retrospective Taiwanese Gynecologic Oncology Group studyGynecologic Oncology, 2015
- Gynecologic Cancer InterGroup (GCIG) Consensus Review for Small Cell Carcinoma of the CervixInternational Journal of Gynecological Cancer, 2014
- Diagnosis, clinicopathologic features, treatment, and prognosis of small cell carcinoma of the uterine cervix; Kansai Clinical Oncology Group/Intergroup study in JapanGynecologic Oncology, 2013
- Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical documentGynecologic Oncology, 2011
- Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patientsAmerican Journal of Obstetrics and Gynecology, 2010
- Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapyGynecologic Oncology, 2009
- Small Cell Carcinoma of the Female Genital TractSeminars in Oncology, 2007
- Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrenceGynecologic Oncology, 2004
- Small-Cell Carcinoma of the Cervix: Fourteen Years of Experience at a Single Institution Using a Combined-Modality Regimen of Involved-Field Irradiation and Platinum-Based Combination ChemotherapyJournal of Clinical Oncology, 2003
- Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute.1997